Archives
-
2,2,2-Trichloroethanol in Translational Protein Analysis
2026-09-26
Explore how 2,2,2-Trichloroethanol can support protein-level checks in research workflows—and why those checks answer different questions from dopamine-transporter PET. A critical reading of a Parkinson’s cell-therapy study shows how to connect molecular biology research with in vivo evidence without conflating the methods.
-
Phosphatase Inhibitor Cocktail 1 for Signaling
2026-09-25
Preserve phosphorylation during cell and tissue lysis with a DMSO-based cocktail formulated to inhibit alkaline and serine/threonine phosphatases. See how to integrate it into Western blot, co-immunoprecipitation, and phosphoproteomic workflows—and how to interpret those assays alongside transcriptional findings in HPV16-positive cancer research.
-
Phosphatase Inhibitor Cocktail 1 for CRC Signaling
2026-09-25
Preserve phosphoprotein readouts when testing colorectal cancer signaling, from p-AKT and p-mTOR Western blots to phosphoproteomic workflows. This practical guide shows how to add a 100X inhibitor stock to lysis steps, control DMSO, and troubleshoot results without implying that the featured CRC study used this reagent.
-
α-Bungarotoxin for Nicotinic Receptor Blockade
2026-09-24
Use α-Bungarotoxin to test whether α7 nicotinic acetylcholine receptor signaling is required for a cellular response—not merely associated with it. A recent placental ischemia study illustrates how antagonist reversal can connect cholinergic signaling to necroptosis, inflammation, and trophoblast behavior, while offering a practical framework for controlled follow-up experiments.
-
SNS-032: Interpreting CDK Inhibition Across Cell Systems
2026-09-24
SNS-032 (BMS-387032) inhibits CDK2, CDK7, and CDK9, but its effects must be interpreted across phosphorylation, protein abundance, and cell-state readouts. This article connects cancer-research workflows with a 2026 SARS-CoV-2 host-factor study while clearly distinguishing its CDK9 inhibitor from SNS-032.
-
PDGF-BB Assays for Vascular Remodeling Research
2026-09-23
Use murine recombinant PDGF-BB as a defined mitogenic stimulus to benchmark smooth muscle cell proliferation alongside hypoxia-driven pulmonary vascular remodeling. This workflow pairs practical dose-finding and handling guidance with clear limits: PDGF-BB is an experimental comparator, not a substitute for the ALDOB–DRP1 mechanism described in the reference study.
-
Protein A/G Magnetic Co-IP/IP Kit for AP2-M
2026-09-23
Learn how the Protein A/G Magnetic Co-IP/IP Kit can complement chromatin, transcriptomic, and proteomic studies of Babesia AP2-M. This article develops a parasite-focused strategy for testing physical protein complexes without confusing interaction evidence with DNA-binding or expression data.
-
Trypsin Workflows for Cell and Protein Research
2026-09-22
Translate the predictable cleavage of this serine protease into practical protein-digestion, cell-handling, wound-healing, and membrane-fusion workflows. This guide combines executable starting conditions with troubleshooting and a carefully bounded connection to advanced NIR-II tumor-therapy research.
-
Phosphatase Inhibitor Cocktail 1: Assay Logic
2026-09-22
Phosphatase Inhibitor Cocktail 1 is more than a routine lysis additive: it is an endpoint-control tool for protein phosphorylation preservation. This guide connects its selective inhibitor chemistry with chromatin-focused research and practical decisions in phosphoproteomic analysis, Western blotting, and signaling assays.
-
Metal-Free Carbon Nanozymes for ALP Detection
2026-09-21
The reference study introduces metal-free carbon dots whose nanozyme activity is reversibly controlled by pyrophosphate, enabling a colorimetric alkaline phosphatase assay without metal-ion cofactors. Michaelis–Menten analysis shows that pyrophosphate inhibits the carbon-dot catalyst at a site distinct from its catalytic site, supporting an analytical range of 0.010–0.200 U/L and a detection limit of 0.009 U/L.
-
2,2,2-Trichloroethanol for Protein Analysis
2026-09-21
2,2,2-Trichloroethanol is a soluble small-molecule reagent for adding rapid protein visualization and modification steps to electrophoresis workflows. This article shows how to use it as an orthogonal quality-control tool alongside DAT imaging, histology, and functional assays in molecular biology research.
-
IGU Prodrug Disrupts RA FLS–Macrophage Crosstalk
2026-09-20
This 2026 Journal of Orthopaedic Translation study identifies TYK2 JH2-dependent STAT1 signaling as a mechanism through which iguratimod suppresses rheumatoid arthritis fibroblast-like synoviocyte invasiveness. It also defines a STAT1–C3–TNFα feedback loop between synovial fibroblasts and macrophages and introduces the orally active prodrug AD811 as a pharmacokinetically improved iguratimod derivative.
-
CB-5083 Workflow for p97 Stress-Response Studies
2026-09-19
CB-5083 enables controlled p97 inhibition for linking ubiquitin-dependent proteostasis disruption with ER-stress and stress-granule phenotypes. This workflow separates biochemical potency from cellular response, helping researchers optimize oncology, multiple myeloma, and protein-quality-control experiments.
-
Lysis Buffer for Rapid Mouse Genotyping
2026-09-18
Lysis buffer H1002 is a rapid genotyping kit component for mouse tail, toe, and ear tissue. When paired with proteinase K and an equilibration buffer, it supports genomic DNA release from mouse tail samples for research-oriented genetic analysis.
-
3X FLAG Peptide: From Mechanism to Translation
2026-09-18
A mechanistic and strategic guide to using the 3X (DYKDDDDK) Peptide in recombinant protein purification, FLAG fusion detection, membrane-protein validation, and translational structural biology, informed by recent insights into NINJ1-mediated plasma membrane rupture.